4//SEC Filing
Fleming Michael 4
Accession 0001127602-20-015657
CIK 0000310158other
Filed
May 5, 8:00 PM ET
Accepted
May 6, 5:16 PM ET
Size
13.4 KB
Accession
0001127602-20-015657
Insider Transaction Report
Form 4
Fleming Michael
SVP Chief Ethics & Com Officer
Transactions
- Exercise/Conversion
Common Stock
2020-05-04$77.67/sh+692$53,748→ 6,252.334 total - Tax Payment
Common Stock
2020-05-04$77.67/sh−238$18,485→ 6,014.334 total - Exercise/Conversion
Restricted Stock Unit
2020-05-05−1,290→ 0 totalFrom: 2020-05-05Exp: 2020-05-05→ Common Stock (1,290 underlying) - Exercise/Conversion
Common Stock
2020-05-05$76.86/sh+1,290$99,149→ 7,304.334 total - Tax Payment
Common Stock
2020-05-05$76.86/sh−458$35,202→ 6,846.334 total - Exercise/Conversion
Restricted Stock Unit
2020-05-04−692→ 694 totalFrom: 2019-05-04Exp: 2021-05-04→ Common Stock (692 underlying)
Footnotes (3)
- [F1]Holdings include shares acquired in dividend reinvestment transactions.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F3]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.
Documents
Issuer
Merck & Co., Inc.
CIK 0000310158
Entity typeother
Related Parties
1- filerCIK 0001772183
Filing Metadata
- Form type
- 4
- Filed
- May 5, 8:00 PM ET
- Accepted
- May 6, 5:16 PM ET
- Size
- 13.4 KB